Melfalan
Melfalan je organsko jedinjenje, koje sadrži 13 atoma ugljenika i ima molekulsku masu od 305,200 Da.[1][2][3][4][5]
| Klinički podaci | |
|---|---|
| Prodajno ime | Alkeran, L-PAM, L-Phenylalanine mustard, L-Sarcolysin |
| Drugs.com | Monografija |
| Način primene | Oralno |
| Farmakokinetički podaci | |
| Poluvreme eliminacije | 1,5 h |
| Identifikatori | |
| CAS broj | 148-82-3 |
| ATC kod | L01AA03 (WHO) |
| PubChem | CID 4053 |
| DrugBank | DB01042 |
| ChemSpider | 405297 |
| ChEBI | CHEBI:28876 |
| ChEMBL | CHEMBL852 |
| Hemijski podaci | |
| Formula | C13H18Cl2N2O2 |
| Molarna masa | 305,200 |
| |
| |
| Fizički podaci | |
| Tačka topljenja | 1.825 °C (3.317 °F) |
Osobine
уреди| Osobina | Vrednost |
|---|---|
| Broj akceptora vodonika | 4 |
| Broj donora vodonika | 2 |
| Broj rotacionih veza | 8 |
| Particioni koeficijent[6] (ALogP) | -0,1 |
| Rastvorljivost[7] (logS, log(mol/L)) | -4,0 |
| Polarna površina[8] (PSA, Å2) | 66,6 |
Reference
уреди- ^ Loeber R, Michaelson E, Fang Q, Campbell C, Pegg AE, Tretyakova N. . „Cross-linking of the DNA repair protein Omicron6-alkylguanine DNA alkyltransferase to DNA in the presence of antitumor nitrogen mustards”. Chem Res Toxicol. 21 (4): 787—95. 2008 Apr. PMID 18324787. Проверите вредност парамет(а)ра за датум:
|date=(помоћ) Feb 14. - ^ Souliotis VL, Dimopoulos MA, Episkopou HG, Kyrtopoulos SA, Sfikakis PP: Preferential in vivo DNA repair of melphalan-induced damage in human genes is greatly affected by the local chromatin structure. DNA Repair (Amst). . . 5 (8): 972—85. 2006 Aug 13. PMID 16781199. Проверите вредност парамет(а)ра за датум:
|date=(помоћ); Недостаје или је празан параметар|title=(помоћ) Jun 15. - ^ Moscow JA, Swanson CA, Cowan KH. . „Decreased melphalan accumulation in a human breast cancer cell line selected for resistance to melphalan”. Br J Cancer. 68 (4): 732—7. 1993 Oct. PMID 8398701. Проверите вредност парамет(а)ра за датум:
|date=(помоћ) - ^ Knox, C.; Law, V.; Jewison, T.; Liu, P.; Ly, S.; Frolkis, A.; Pon, A.; Banco, K.; Mak, C.; Neveu, V.; Djoumbou, Y.; Eisner, R.; Guo, A. C.; Wishart, D. S. (2011). . „DrugBank 3.0: A comprehensive resource for 'Omics' research on drugs”. Nucleic Acids Research. 39 (Database issue): D1035—D1041. PMC 3013709 . PMID 21059682. doi:10.1093/nar/gkq1126.
- ^ Wishart, David S.; Knox, Craig; Guo, An Chi; Cheng, Dean; Shrivastava, Savita; Tzur, Dan; Gautam, Bijaya; Hassanali, Murtaza (2008). . „DrugBank: A knowledgebase for drugs, drug actions and drug targets”. Nucleic Acids Research. 36 (Database issue): D901—D906. PMC 2238889 . PMID 18048412. doi:10.1093/nar/gkm958.
- ^ Ghose, Arup K.; Viswanadhan, Vellarkad N.; Wendoloski, John J. (1998). . „Prediction of Hydrophobic (Lipophilic) Properties of Small Organic Molecules Using Fragmental Methods: An Analysis of ALOGP and CLOGP Methods”. The Journal of Physical Chemistry A. 102 (21): 3762—3772. Bibcode:1998JPCA..102.3762G. doi:10.1021/jp980230o.
- ^ Tetko, Igor V.; Tanchuk, Vsevolod Yu.; Kasheva, Tamara N.; Villa, Alessandro E. P. (2001). . „Estimation of Aqueous Solubility of Chemical Compounds Using E-State Indices”. Journal of Chemical Information and Computer Sciences. 41 (6): 1488—1493. PMID 11749573. doi:10.1021/ci000392t.
- ^ Ertl, Peter; Rohde, Bernhard; Selzer, Paul (2000). . „Fast Calculation of Molecular Polar Surface Area as a Sum of Fragment-Based Contributions and Its Application to the Prediction of Drug Transport Properties”. Journal of Medicinal Chemistry. 43 (20): 3714—3717. PMID 11020286. doi:10.1021/jm000942e.
Literatura
уреди- Hardman JG, Limbird LE, Gilman AG (2001). Goodman & Gilman's The Pharmacological Basis of Therapeutics (10. изд.). New York: McGraw-Hill. ISBN 0071354697. doi:10.1036/0071422803.
- Thomas L. Lemke; David A. Williams, ур. (2007). Foye's Principles of Medicinal Chemistry (6. изд.). Baltimore: Lippincott Willams & Wilkins. ISBN 0781768799.
Spoljašnje veze
уреди
| Molimo Vas, obratite pažnju na važno upozorenje u vezi sa temama iz oblasti medicine (zdravlja). |